0001073397-21-000003.txt : 20210416 0001073397-21-000003.hdr.sgml : 20210416 20210416195906 ACCESSION NUMBER: 0001073397-21-000003 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210415 FILED AS OF DATE: 20210416 DATE AS OF CHANGE: 20210416 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LOPEZ GEORGE A CENTRAL INDEX KEY: 0001073397 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 21832778 MAIL ADDRESS: STREET 1: C/O ICU MEDICAL STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-04-15 0 0000883984 ICU MEDICAL INC/DE ICUI 0001073397 LOPEZ GEORGE A 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 0 1 0 Common Stock 2021-04-15 4 S 0 630 206.7094 D 936213 I by Partnership Common Stock 2021-04-15 4 S 0 8412 207.6788 D 927801 I by Partnership Common Stock 2021-04-15 4 S 0 5658 208.6166 D 922143 I by Partnership Common Stock 2021-04-15 4 S 0 200 209.31 D 921943 I by Partnership Common Stock 2021-04-16 4 S 0 1454 207.6511 D 920489 I by Partnership Common Stock 2021-04-16 4 S 0 977 208.7857 D 919512 I by Partnership Common Stock 2021-04-16 4 S 0 2597 210.0092 D 916915 I by Partnership Common Stock 2021-04-16 4 S 0 1608 211.0294 D 915307 I by Partnership Common Stock 2021-04-16 4 S 0 1905 211.81 D 913402 I by Partnership Common Stock 2021-04-16 4 S 0 1559 212.7818 D 911843 I by Partnership Common Stock 240314 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 2, 2021. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $206.15 to 207.13, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.22 to 208.21, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.23 to 209.11, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. All shares sold were sold at the exact price disclosed. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $207.13 to 207.93, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $208.28 to 209.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $209.43 to 210.37, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $210.44 to 211.39, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $211.45 to 212.44, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $212.52 to 213.17, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D. 2021-04-16